Trial Profile
A Phase I, Open-label, Randomized, Three-period Cross-over Study Evaluating the Effect of Cyclosporine on the Pharmacokinetics of Eltrombopag in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Sep 2023
Price :
$35
*
At a glance
- Drugs Eltrombopag (Primary) ; Ciclosporin
- Indications Aplastic anaemia; Idiopathic thrombocytopenic purpura; Thrombocytopenia
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 18 Jan 2015 Status changed from not yet recruiting to completed, as reported by ClinicalTrials.gov.
- 05 Nov 2014 New trial record